You have 9 free searches left this month | for more free features.

RT-01

Showing 1 - 25 of 5,110

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

T-cell Lymphoma, Virus, Intravenous Injection Trial (Oncolytic Virus Injection(RT-01))

Not yet recruiting
  • T-cell Lymphoma
  • +2 more
  • Oncolytic Virus Injection(RT-01)
  • (no location specified)
May 18, 2022

Advanced Solid Tumor Trial in Xuzhou (Oncolytic Virus Injection(RT-01))

Recruiting
  • Advanced Solid Tumor
  • Oncolytic Virus Injection(RT-01)
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
May 4, 2022

Solid Tumor, Advanced Cancer Trial in Wuxi (Oncolytic Virus Injection(RT-01))

Recruiting
  • Solid Tumor
  • Advanced Cancer
  • Oncolytic Virus Injection(RT-01)
  • Wuxi, Jiangsu, China
    Wuxi People's Hospital
Jan 19, 2022

Advanced Solid Tumor Trial in Wuxi (Oncolytic Virus Injection (RT-01))

Recruiting
  • Advanced Solid Tumor
  • Oncolytic Virus Injection (RT-01)
  • Wuxi, Jiangsu, China
    Wuxi People's Hospital
Jan 19, 2022

Healthy Volunteer Trial in Prahran (Drug: RT234 - vardenafil inhalation powder; Device: RS01 dry powder inhaler (RS01 DPI),

Completed
  • Healthy Volunteer
  • Drug: RT234 - vardenafil inhalation powder; Device: RS01 dry powder inhaler (RS01 DPI)
  • Vardenafil Oral Tablet
  • Prahran, Victoria, Australia
    Nucleus Network, Burnet Institute
Nov 2, 2022

Skin Cancer, Non-Melanoma Trial (Surgery with additional moderate hypofractionation RT (15 fractions), Surgery alone, without

Not yet recruiting
  • Skin Cancer, Non-Melanoma
  • Surgery with additional moderate hypofractionation RT (15 fractions)
  • +2 more
  • (no location specified)
Mar 20, 2023

Pulmonary Arterial Hypertension Trial in Darlinghurst, Hobart, Melbourne (Drug: RT234 - vardenafil inhalation powder; Device:

Completed
  • Pulmonary Arterial Hypertension
  • Drug: RT234 - vardenafil inhalation powder; Device: RS01 dry powder inhaler (RS01 DPI)
  • Darlinghurst, New South Wales, Australia
  • +2 more
Apr 20, 2022

Extensive-stage Small-cell Lung Cancer Trial in Sydney, Brisbane, Melbourne (Radiotherapy, Chemotherapy)

Recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Sydney, New South Wales, Australia
  • +6 more
Mar 21, 2023

Anal Cancer Trial run by the NCI (Tempol, 5-Fluorouracil, Mitomycin-C)

Terminated
  • Anal Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 25, 2021

Carcinosarcoma, Endometrial Tumors Trial in United Kingdom (Paclitaxel, Cediranib, Olaparib)

Active, not recruiting
  • Carcinosarcoma
  • Endometrial Neoplasms
  • Northwood, Middlesex, United Kingdom
  • +14 more
Feb 10, 2022

HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Australia, New Zealand (Cetuximab, RT (70 Gy in 35 fractions),

Active, not recruiting
  • HPV Positive Oropharyngeal Squamous Cell Carcinoma
  • Canberra, Australian Capital Territory, Australia
  • +15 more
Feb 7, 2021

COVID-19, Infectious Disease, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in United States (RQ-001, Placebo)

Recruiting
  • COVID-19
  • +3 more
  • RQ-001
  • Placebo
  • Cullman, Alabama
  • +8 more
Sep 28, 2023

Eczema, Atopic Dermatitis Trial in Worldwide (KY1005, Placebo)

Active, not recruiting
  • Eczema
  • Atopic Dermatitis
  • Fremont, California
  • +102 more
Dec 13, 2022

Hepatocellular Carcinoma, Hepatitis b Virus, Radiotherapy Trial

Not yet recruiting
  • Hepatocellular Carcinoma
  • +3 more
    • (no location specified)
    Feb 21, 2023

    Gene Signatures Searching of Sensitivity/Resistance to

    Recruiting
    • Soft Tissue Sarcomas
    • pre-operative radiation
    • Standard surgery after rpreoprative radiation
    • Lyon, France
      Centre Léon Bérard
    Feb 20, 2023

    Tumor Recurrence Following Radiotherapy

    Recruiting
    • Prostate Cancer
      • Rochester, Minnesota
        Mayo Clinic
      Jan 20, 2023

      Glioblastoma Multiforme, Adult Trial (Adaptive, two-phase RT)

      Not yet recruiting
      • Glioblastoma Multiforme, Adult
      • Adaptive, two-phase RT
      • (no location specified)
      Feb 8, 2023

      Improving Outcomes for Older Adults Undergoing Radiation Therapy

      Recruiting
      • Cancer
      • Radiation Therapy
        • New York, New York
          One Gustave L Levy Place
        Jan 31, 2023

        Atopic Dermatitis Trial in Worldwide (ZPL389 30mg, ZPL389 50mg, TCS and/or TCI)

        Terminated
        • Atopic Dermatitis
        • ZPL389 30mg
        • +2 more
        • Litchfield Park, Arizona
        • +47 more
        Oct 7, 2021

        Breast Cancer, Radiation Toxicity Trial in Ghent (Radiotherapy)

        Completed
        • Breast Cancer
        • Radiation Toxicity
        • Radiotherapy
        • Ghent, Oost-Vlaanderen, Belgium
        • +1 more
        Jan 3, 2023

        Alpha-synuclein Rt-quic and Neurologic Symptoms in Persons With

        Recruiting
        • Idiopathic Anosmia
        • +2 more
        • RT-QuiC
        • Copenhagen, Denmark
        • +1 more
        Feb 22, 2023

        CEA mRNA in Smog and Tissue Exudate Whole Process Collected

        Recruiting
        • Gastric Cancer
        • Radical Gastric Cancer Surgery
        • Qingdao, Shandong, China
          The Affiliated Hospital of Qingdao University
        Oct 7, 2023

        Psoriasis Trial in Worldwide (Risankizumab)

        Enrolling by invitation
        • Psoriasis
        • Fountain Valley, California
        • +36 more
        Jan 24, 2023

        Glioblastoma Multiforme Trial in Toronto (Reduced margin adaptive radiotherapy)

        Recruiting
        • Glioblastoma Multiforme
        • Reduced margin adaptive radiotherapy
        • Toronto, Ontario, Canada
          Sunnybrook Health Sciences Centre
        Oct 19, 2022

        Radiomics-based Malnutrition for Cervical Cancer.

        Not yet recruiting
        • Cervical Cancer
        • Malnutrition
        • There are no interventions.
        • Hangzhou, Zhejiang, China
          Zhejiang Provincial People's Hospital
        Jan 24, 2023